Effect of IL-6 receptor inhibition on infarct volume after endovascular treatment for ischaemic stroke: a phase 2, randomised, placebo-controlled trial
Xuehong Chu(Capital Medical University), Hongrui Ma(Capital Medical University), Changming Wen(Nanyang Institute of Technology), Yunjian Yin(Capital Medical University), Benxiao Wang, Jianqiao Li(Huaibei Mining (China)), Chuanjie Wu(Capital Medical University), Jing Lan(Hong Kong Polytechnic University), Jean Claude Baron(Inserm), Xiaole Jia(Capital Medical University), Shuxiang Yang(Zunyi Medical University), Arthur Liesz(LMU Klinikum), Chuanhui Li(Capital Medical University), Chaoqun Li(Capital Medical University), Hongqiu Gu(Capital Medical University), Marc Fisher(Beth Israel Deaconess Medical Center), Wenbo Zhao(Capital Medical University), Le Chen, Meijuan Kang, Guiyou Liu(Capital Medical University), Zhengfei Ma(Suzhou Municipal Hospital), David S. Liebeskind(University of California, Los Angeles), Ning Wang(Nanyang Institute of Technology), Jun Sun(Nanyang Institute of Technology), Biluo Liu, Xiao Dong(Capital Medical University), Yan Liu(Nanyang Institute of Technology), Chen Zhou(Capital Medical University), Lei Wang, Yongxing Su(Capital Medical University), Anzhi Li, Jiaxiang Li(Huaibei Mining (China)), Hanming Ye, Yifeng Liu(Nanyang Institute of Technology), Qi Zhang, Chunxue Wu(Capital Medical University), Yan Feng(Suzhou Municipal Hospital), Xiangyang Feng(Zhoukou City Academy of Agricultural Sciences), Mingde Fang(Hebei University of Engineering), Xunming Ji(Chinese Institute for Brain Research)
Cited by 7
Related Papers
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|New England Journal of Medicine|2022|707
Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion
|New England Journal of Medicine|2022|665
Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial
|Cephalalgia|2012|217